Novo Nordisk Clinical Trial Patients Affected by Data Breach

Novo Nordisk, the pharmaceutical company that makes diabetes and weight loss medications, has reported a data breach. The company discovered a security incident that may have exposed information about people who participated in their clinical trials. Novo Nordisk has begun notifying affected patients.

If you or a family member participated in a clinical trial for Novo Nordisk, your personal information may have been exposed. This could include your name, contact details, medical information related to the trial, and other sensitive data. The company has stated it is telling clinical trial patients to remain vigilant. You should receive a notice directly from Novo Nordisk if your information was involved.

1. Watch your mail and email for an official notification from Novo Nordisk with specific details about what information was affected.
2. Monitor your medical records and insurance statements for any unfamiliar activity or charges.
3. Be alert for phone calls or emails from people claiming to be medical professionals who already know about your health conditions. These could be scammers using the stolen data.
4. Consider placing a fraud alert on your credit report, especially if the notification letter indicates financial information was exposed.
5. Report any suspicious activity to Novo Nordisk and your local authorities. Protect yourself going forward by reviewing all medical and insurance statements carefully each month. Ask your doctors and clinical trial coordinators what security measures they use to protect your information. Never share medical details or personal information over the phone unless you initiated the call. Keep a list of which clinical trials or medical studies you have participated in so you can quickly respond if another breach occurs.